The store will not work correctly when cookies are disabled.
7-hydroxy efavirenz
ID: ALA3526537
Cas Number: 252343-24-1
PubChem CID: 40621976
Max Phase: Preclinical
Molecular Formula: C14H9ClF3NO3
Molecular Weight: 331.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1Nc2cc(O)c(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1
Standard InChI: InChI=1S/C14H9ClF3NO3/c15-9-5-8-10(6-11(9)20)19-12(21)22-13(8,14(16,17)18)4-3-7-1-2-7/h5-7,20H,1-2H2,(H,19,21)/t13-/m0/s1
Standard InChI Key: GZMDZAYFVCXHFM-ZDUSSCGKSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.0988 -5.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6861 -5.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3972 -4.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8376 -4.0529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5033 -5.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8211 -4.8660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1319 -3.6278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4137 -4.0282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2816 -6.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8648 -7.3877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6791 -5.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1590 -7.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8689 -8.2132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5599 -3.6526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7038 -3.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0947 -6.6861 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.3287 -5.9762 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.9160 -6.6861 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.9692 -4.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9898 -3.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2510 -5.2127 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2918 -3.5702 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 6 1 0
1 5 1 6
6 1 1 0
7 4 1 0
8 3 1 0
9 2 3 0
10 9 1 0
11 3 2 0
12 10 1 0
13 10 1 0
14 4 2 0
15 8 2 0
16 5 1 0
17 5 1 0
18 5 1 0
19 11 1 0
20 19 2 0
21 19 1 0
8 7 1 0
20 15 1 0
12 13 1 0
20 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.68 | Molecular Weight (Monoisotopic): 331.0223 | AlogP: 3.78 | #Rotatable Bonds: ┄ |
Polar Surface Area: 58.56 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.54 | CX Basic pKa: ┄ | CX LogP: 4.15 | CX LogD: 3.92 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.71 | Np Likeness Score: 0.56 |
References
1. Avery LB, VanAusdall JL, Hendrix CW, Bumpus NN.. (2013) Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid., 41 (2): [PMID:23166317] [10.1124/dmd.112.049601] |